Norton Law Corporation has launched an easier way for clients to purchase their legal services online.
Broden & Mickelsen has announced a scholarship for Texas law students currently employed or pursuing employment with a Federal or State Public Defender’s Office.
The attorneys working with ClassAction.org are now reviewing claims on behalf of homeowners whose Vinyl Clad Ply Gem windows leaked or failed prematurely, resulting in water damage to the window, walls, flooring and other surrounding property.
A class action lawsuit alleges that certain hardwood flooring sold by Lumber Liquidators off-gasses more than three times the legal limit of formaldehyde, and that the company illegally sources its wood products from China and other countries inh ...
Multiple class action lawsuits have been filed against Atlas Roofing Corporation with property owners alleging that the company’s Chalet shingles can crack, blister and fail prematurely due to a manufacturing defect, ClassAction.org reports.
The attorneys working with ClassAction.org are now reviewing claims on behalf of property owners who experienced problems with their Pella windows, such as wood rot, mold growth or other water damage.
Lawsuits filed against the maker of prescription testosterone AndroGel allege that nearly a quarter of men who were prescribed testosterone replacement therapies never had their testosterone levels tested first, ClassAction.org reports.
The plaintiffs in Risperdal gynecomastia lawsuits asked the Honorable Judge Arnold New to reject Janssen Pharmaceuticals Inc.’s bid to dismiss plaintiffs’ punitive damages claims, arguing that the drug company wrongly seeks to apply a statute of ...
Lawsuits that have been filed over the contraceptive Mirena allege that postpartum women are at an increased risk for perforation of the uterine wall or cervix, which may lead to infections, scars or hemorrhages.
A new study published in the European Journal of Preventive Cardiology found that patients using statins like Lipitor were at a higher risk for developing new-onset type 2 diabetes, ClassAction.org reports.
ClassAction.org is reporting that women who were injured after being fitted with the Mirena IUD allege that the device’s manufacturer made false and misleading statements about the contraceptive through a marketing campaign known as “Mirena parties.”
ClassAction.org is reporting that lawsuits allege Janssen Pharmaceuticals promoted its antipsychotic drug Risperdal for off-label uses including the treatment of schizophrenia in adolescents.
The attorneys working with ClassAction.org are currently investigating potential lawsuits for women who were diagnosed with type 2 diabetes after using the cholesterol-lowering drug Lipitor.
Lawsuits allege that Abbott Laboratories Inc. took part in “disease mongering” when it promoted its testosterone replacement therapy AndroGel for symptoms that are also natural signs of aging, such as fatigue and loss of stamina, ClassAction.org ...
Women who developed type 2 diabetes after using the cholesterol-lowering drug Lipitor are seeking compensation for medical bills, physical and emotional injuries and pain and suffering, ClassAction.org reports.
Bernard F. Walsh and other top attorneys practicing in the Sarasota/Bradenton area gathered together for the Manasota Trial Lawyers Board Dinner and Seminar in Lakewood Ranch.
ClassAction.org is reporting that a class action lawsuit has been filed in Illinois over Pella’s Architect and Designer model windows alleging that they are defective and prone to moisture retention, which can cause rotting, mold growth and leaks.
The Honorable Judge Cathy Seibel has extended several bellwether trial deadlines by 60 days, allowing both sides an additional two months to complete certain discovery processes, ClassAction.org reports.
Janssen Pharmaceuticals Inc. will pay $5.9 million to settle claims brought by Montana Attorney General Timothy C. Fox that the company deceptively advertised its antipsychotic drug Risperdal, ClassAction.org reports.
Johnson & Johnson and its subsidiary Janssen Pharmaceuticals argued that the Arkansas Supreme Court should reverse a $1.2 billion marketing fine in a case filed by the Arkansas Attorney General alleging that the company improperly marketed its an ...